Fractional CO₂ laser systems represent a well-established modality for ablative skin treatment and are widely regarded in the contemporary literature as the gold standard for laser skin resurfacing. The clinical outcome and safety of the procedure depend not only on the laser system parameters but also, to a considerable extent, on appropriate patient selection and adequate post-procedure care, both of which directly influence the incidence of complications and the overall aesthetic outcome. In this context, pre-procedural assessment and risk stratification play a key role in ensuring treatment safety. The aim of this second part of the narrative review is to examine the role of the medical aesthetician in the process of patient selection and the provision of appropriate post-procedure care following fractional CO₂ laser therapy. Particular emphasis is placed on defining the boundaries of professional competence, as well as on the importance of the timely recognition of high-risk conditions requiring referral to a medical specialist.
Within their scope of professional competence, medical aestheticians may contribute to treatment safety by performing an initial assessment of the patient's skin condition, identifying potential risk factors, educating patients regarding pre-procedure preparation and post-procedure care, and ensuring timely referral to a medical specialist when contraindications are identified or complications are suspected.
Future clinical and organizational studies are warranted to evaluate the impact of implementing standardized practice algorithms for medical aestheticians on the quality of care, the incidence of complications, and patient satisfaction.
Alexiades-Armenakas MR, Dover JS, Arndt KA. The spectrum of laser skin resurfacing. J Am Acad Dermatol. 2014;70(5):891–925.
Alster TS, Tanzi EL. Effect of a novel low-energy pulsed-light device for home-use hair removal. Dermatol Surg. 2009;35:483–9.
Alster TS, Li MKY. Microneedling of scars: a large prospective study with long-term follow-up. Plast Reconstr Surg. 2020;145(2):358–64.
Alster TS, Tanzi EL. Laser skin resurfacing: ablative and non-ablative. In: Surgery of the Skin. Mosby; 2005. p. 611–24.
Chan H. The use of lasers and intense pulsed light sources for the treatment of acquired pigmentary lesions in Asians. J Cosmet Laser Ther. 2003;5(3–4):198–200.
Chapas AM, Brightman L, Sukal S, et al. Successful treatment of acneiform scarring with CO₂ ablative fractional resurfacing. Lasers Surg Med. 2008;40(6):381–6.
Fitzpatrick TB. The validity and practicality of sun-reactive skin types I through VI. Arch Dermatol. 1988;124(6):869–71.
Haggerty JL, Reid RJ, Freeman GK, et al. Continuity of care: a multidisciplinary review. BMJ. 2003;327:1219–21.
Hantash BM, Bedi VP, Kapadia B, et al. In vivo histological evaluation of a novel ablative fractional resurfacing device. Lasers Surg Med. 2007;39(2):96–107.
Nanni CA, Alster TS. Complications of carbon dioxide laser resurfacing: an evaluation of 500 patients. Dermatol Surg. 1998;24(3):315–20.
Ramsdell WM. Fractional CO₂ laser resurfacing complications. Semin Plast Surg. 2012;26(3):137–40.
Ross EV, McKinlay JR, Anderson RR. Why does carbon dioxide resurfacing work? A review. Arch Dermatol. 1999;135(4):444–54.
Tan KL, Kurniawati C, Gold MH. Low risk of postinflammatory hyperpigmentation in skin types IV and V after treatment with a fractional CO₂ laser device. J Drugs Dermatol. 2008;7(8):774–7.
Tierney EP, Eisen RF, Hanke CW. Fractionated CO₂ laser skin rejuvenation. Dermatol Ther. 2011;24:41–53.
